Terms: = Lung cancer AND FLT4, FLT41, 2324, ENSG00000037280, P35916, VEGFR3, PCL
280 results:
1. Recent development of VEGFR small molecule inhibitors as anticancer agents: A patent review (2021-2023).
Zeng J; Deng Q; Chen Z; Yan S; Dong Q; Zhang Y; Cui Y; Li L; He Y; Shi J
Bioorg Chem; 2024 May; 146():107278. PubMed ID: 38484586
[TBL] [Abstract] [Full Text] [Related]
2. Longitudinal plasma proteomic analysis identifies biomarkers and combinational targets for anti-PD1-resistant cancer patients.
Tan Q; Gao R; Zhang X; Yang J; Xing P; Yang S; Wang D; Wang G; Wang S; Yao J; Zhang Z; Tang L; Yu X; Han X; Shi Y
Cancer Immunol Immunother; 2024 Feb; 73(3):47. PubMed ID: 38349411
[TBL] [Abstract] [Full Text] [Related]
3. NKX2-1-AS1 promotes the lymphangiogenesis of lung adenocarcinoma through regulation of ERG-mediated FABP4.
Tao T; Chen H; Xu Q; Li Z; Chen X; Zhou X; Luo W
Tissue Cell; 2024 Apr; 87():102314. PubMed ID: 38309204
[TBL] [Abstract] [Full Text] [Related]
4. [A Case of Gastric cancer with Pulmonary Carcinomatous Lymphangitis and Disseminated Carcinomatosis of the Bone Marrow Responding to S-1 plus Cisplatin Chemotherapy].
Otsuka N; Shirayama K
Gan To Kagaku Ryoho; 2023 Dec; 50(12):1319-1321. PubMed ID: 38247072
[TBL] [Abstract] [Full Text] [Related]
5. RETooling the RET Inhibitor Pralsetinib for ESR1 Fusion-Positive Breast cancer and Beyond.
Wu J; Subbiah V
Cancer Res; 2023 Oct; 83(19):3159-3161. PubMed ID: 37779428
[TBL] [Abstract] [Full Text] [Related]
6. Inhalable spray-dried polycaprolactone-based microparticles of Sorafenib Tosylate with promising efficacy on A549 cells.
Yadav KS; Raut HC; Nijhawan HP
Pharm Dev Technol; 2023 Oct; 28(8):755-767. PubMed ID: 37665569
[TBL] [Abstract] [Full Text] [Related]
7. Development and In Vitro Evaluation of Crizotinib-Loaded Lipid-Polymer Hybrid Nanoparticles Using Box-Behnken Design in Non-small Cell lung cancer.
Korucu Aktas P; Baysal I; Yabanoglu-Ciftci S; Arica B
AAPS PharmSciTech; 2023 Sep; 24(7):178. PubMed ID: 37658977
[TBL] [Abstract] [Full Text] [Related]
8. Enzyme/pH dual stimuli-responsive nanoplatform co-deliver disulfiram and doxorubicin for effective treatment of breast cancer lung metastasis.
Xiao P; Tao X; Wang H; Liu H; Feng Y; Zhu Y; Jiang Z; Yin T; Zhang Y; He H; Gou J; Tang X
Expert Opin Drug Deliv; 2023; 20(7):1015-1031. PubMed ID: 37452715
[TBL] [Abstract] [Full Text] [Related]
9. Discovery of novel hypoxia-activated, nitroimidazole constructed multi-target kinase inhibitors on the basis of AZD9291 for the treatment of human lung cancer.
Jia T; Miao R; Zhang J; Zhu H; Zhang C; Zeng L; Zhao Y; Cheng W; Shao J
Bioorg Med Chem; 2023 Aug; 91():117384. PubMed ID: 37356356
[TBL] [Abstract] [Full Text] [Related]
10. m
Fang H; Sun Q; Zhou J; Zhang H; Song Q; Zhang H; Yu G; Guo Y; Huang C; Mou Y; Jia C; Song Y; Liu A; Song K; Lu C; Tian R; Wei S; Yang D; Chen Y; Li T; Wang K; Yu Y; Lv Y; Mo K; Sun P; Yu X; Song X
Mol Cancer; 2023 Jun; 22(1):99. PubMed ID: 37353784
[TBL] [Abstract] [Full Text] [Related]
11. Mechanistic insights into the anti-tumor and anti-metastatic effects of Patrinia villosa aqueous extract in colon cancer via modulation of TGF-β R1-smad2/3-E-cadherin and FAK-RhoA-cofilin pathways.
Yang H; Yue GG; Yuen KK; Gao S; Leung PC; Wong CK; Lau CB
Phytomedicine; 2023 Aug; 117():154900. PubMed ID: 37269754
[TBL] [Abstract] [Full Text] [Related]
12. Chitosan functionalized pcl nanoparticles bearing tyrosine kinase inhibitor osimertinib mesylate for effective lung cancer therapy.
Dhuri A; Sriram A; Aalhate M; Mahajan S; Parida KK; Singh H; Gupta U; Maji I; Guru SK; Singh PK
Pharm Dev Technol; 2023 Jun; 28(5):460-478. PubMed ID: 37092801
[TBL] [Abstract] [Full Text] [Related]
13. Eta polycaprolactone (ε-pcl) implants appear to cause a partial differentiation of breast cancer lung metastasis in a murine model.
Benzon B; Marijan S; Pervan M; Čikeš Čulić V
BMC Cancer; 2023 Apr; 23(1):343. PubMed ID: 37055783
[TBL] [Abstract] [Full Text] [Related]
14. LncRNA H19 promotes tumor angiogenesis in smokers by targeting anti-angiogenic miRNAs.
Shirvaliloo M
Epigenomics; 2023 Jan; 15(2):61-73. PubMed ID: 36802727
[TBL] [Abstract] [Full Text] [Related]
15. The solvent chosen for the manufacturing of electrospun polycaprolactone scaffolds influences cell behavior of lung cancer cells.
Polonio-Alcalá E; Casanova-Batlle E; Puig T; Ciurana J
Sci Rep; 2022 Nov; 12(1):19440. PubMed ID: 36376404
[TBL] [Abstract] [Full Text] [Related]
16. Ginsenoside Rd ameliorates muscle wasting by suppressing the signal transducer and activator of transcription 3 pathway.
Wijaya YT; Setiawan T; Sari IN; Park K; Lee CH; Cho KW; Lee YK; Lim JY; Yoon JK; Lee SH; Kwon HY
J Cachexia Sarcopenia Muscle; 2022 Dec; 13(6):3149-3162. PubMed ID: 36127129
[TBL] [Abstract] [Full Text] [Related]
17. Development and Optimization of Osimertinib-loaded Biodegradable Polymeric Nanoparticles Enhance In-vitro Cytotoxicity in Mutant EGFR NSCLC Cell Models and In-vivo Tumor Reduction in H1975 Xenograft Mice Models.
K SK; Choppala AD
AAPS PharmSciTech; 2022 Jun; 23(5):159. PubMed ID: 35676448
[TBL] [Abstract] [Full Text] [Related]
18. Combination of chemotherapy and immune checkpoint therapy by the immunoconjugates-based nanocomplexes synergistically improves therapeutic efficacy in SCLC.
Tao Z; Kuai X; Wang G; Liu S; Liu K; Zhang H; Xia S; Zhu H
Drug Deliv; 2022 Dec; 29(1):1571-1581. PubMed ID: 35612299
[TBL] [Abstract] [Full Text] [Related]
19. [A prospective cohort study on the clinical value of pelvic peritoneal reconstruction in laparoscopic anterior resection for middle and low rectal cancer].
Ji LQ; Lou Z; Gong HF; Sui JK; Cao FA; Yu GY; Zhu XM; Zheng NX; Meng RG; Zhang W
Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Apr; 25(4):336-341. PubMed ID: 35461202
[No Abstract] [Full Text] [Related]
20. Engineered Nanotopography on the Microfibers of 3D-Printed pcl Scaffolds to Modulate Cellular Responses and Establish an
Jing L; Wang X; Leng B; Zhan N; Liu H; Wang S; Lu Y; Sun J; Huang D
ACS Appl Bio Mater; 2021 Feb; 4(2):1381-1394. PubMed ID: 35014489
[TBL] [Abstract] [Full Text] [Related]
[Next]
